Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Depression 1

Interventions

pembrolizumab 245 Nivolumab 141 Cisplatin 137 Cyclophosphamide 134 Paclitaxel 115 Carboplatin 108 Gemcitabine 98 Radiotherapy 84 Dexamethasone 83 Docetaxel 77 atezolizumab 69 Ipilimumab 67 Fluorouracil 61 Doxorubicin 61 Blood Specimen Collection 59 Bevacizumab 59 Rituximab 55 fludarabine 54 Etoposide 53 Oxaliplatin 52 Lenalidomide 50 Surveys and Questionnaires 49 Prednisone 47 Standard of Care 45 Magnetic Resonance Spectroscopy 45 Radiosurgery 44 Cetuximab 44 lenvatinib 43 Capecitabine 43 durvalumab 42

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Milnacipran × 1 year × Clear all

NCT02783430 2025-12-16

KETAPAL

University Hospital, Lille

Phase 2/3 Completed

Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡